Dose Response Study of EMA401 in Patients With Post-herpetic Neuralgia (PHN)
Clinical trial NCT03094195 · TERMINATED
Trial details
- NCT number
- NCT03094195
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-27
- Primary completion
- 2019-03-07
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.